Europe Microneedle Drug Delivery Systems Market By Type (Hollow, Dissolving, Solid, Coated, and Other Types), By Material (Metal, Polymer, Silicon and Other Material), By Application (Drug delivery, Cancer Therapy, Vaccine delivery, Pain Management, Dermatology and Other Applications), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microneedle Drug Delivery Systems Market, by Type
1.4.2 Europe Microneedle Drug Delivery Systems Market, by Application
1.4.3 Europe Microneedle Drug Delivery Systems Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Industry Wide Strategic Developments - Global
3.1 Partnerships, Collaborations and Agreements
3.2 Product Launches and Product Expansions
3.3 Acquisition and Mergers
3.4 Geographical Expansions
3.5 Top Winning Strategies
3.5.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.5.2 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players

Chapter 4. Europe Microneedle Drug Delivery Systems Market by Type
4.1 Europe Hollow Market by Country
4.2 Europe Dissolving Market by Country
4.3 Europe Solid Market by Country
4.4 Europe Coated Market by Country
4.5 Europe Other Types Market by Country

Chapter 5. Europe Microneedle Drug Delivery Systems Market by Application
5.1 Europe Drug delivery Market by Country
5.2 Europe Cancer Therapy Market by Country
5.3 Europe Vaccine delivery Market by Country
5.4 Europe Pain Management Market by Country
5.5 Europe Dermatology Market by Country
5.6 Europe Other Applications Market by Country

Chapter 6. Europe Microneedle Drug Delivery Systems Market by Material
6.1 Europe Metal Market by Country
6.2 Europe Polymer Market by Country
6.3 Europe Silicon Market by Country
6.4 Europe Other Material Market by Country

Chapter 7. Europe Microneedle Drug Delivery Systems Market by Country
7.1 Germany Microneedle Drug Delivery Systems Market
7.1.1 Germany Microneedle Drug Delivery Systems Market by Type
7.1.2 Germany Microneedle Drug Delivery Systems Market by Application
7.1.3 Germany Microneedle Drug Delivery Systems Market by Material
7.2 UK Microneedle Drug Delivery Systems Market
7.2.1 UK Microneedle Drug Delivery Systems Market by Type
7.2.2 UK Microneedle Drug Delivery Systems Market by Application
7.2.3 UK Microneedle Drug Delivery Systems Market by Material
7.3 France Microneedle Drug Delivery Systems Market
7.3.1 France Microneedle Drug Delivery Systems Market by Type
7.3.2 France Microneedle Drug Delivery Systems Market by Application
7.3.3 France Microneedle Drug Delivery Systems Market by Material
7.4 Russia Microneedle Drug Delivery Systems Market
7.4.1 Russia Microneedle Drug Delivery Systems Market by Type
7.4.2 Russia Microneedle Drug Delivery Systems Market by Application
7.4.3 Russia Microneedle Drug Delivery Systems Market by Material
7.5 Spain Microneedle Drug Delivery Systems Market
7.5.1 Spain Microneedle Drug Delivery Systems Market by Type
7.5.2 Spain Microneedle Drug Delivery Systems Market by Application
7.5.3 Spain Microneedle Drug Delivery Systems Market by Material
7.6 Italy Microneedle Drug Delivery Systems Market
7.6.1 Italy Microneedle Drug Delivery Systems Market by Type
7.6.2 Italy Microneedle Drug Delivery Systems Market by Application
7.6.3 Italy Microneedle Drug Delivery Systems Market by Material
7.7 Rest of Europe Microneedle Drug Delivery Systems Market
7.7.1 Rest of Europe Microneedle Drug Delivery Systems Market by Type
7.7.2 Rest of Europe Microneedle Drug Delivery Systems Market by Application
7.7.3 Rest of Europe Microneedle Drug Delivery Systems Market by Material

Chapter 8. Company Profiles
8.1 Nitto Denko Corporation
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments:
8.1.4.1 Partnerships, Collaborations, and Agreements:
8.1.4.2 Product Launches and Product Expansions:
8.2 Becton, Dickinson and Company
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Acquisition and Mergers:
8.2.5.3 Geographical Expansions:
8.3 AdminMed nanoBioSciences LLC
8.3.1 Company Overview
8.4 Zosano Pharma Corporation
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.5 Raphas Co., Ltd.
8.5.1 Company Overview
8.6 Nanopass Technologies Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Corium Inc. (Gurnet Point Capital)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Zealand Pharma A/S (Valeritas, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Research & Development Expenses
8.8.4 Recent strategies and developments:
8.8.4.1 Geographical Expansions:
8.9 Endoderma Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Geographical Expansions:
8.10. Innoture Medical Technology Limited
8.10.1 Company Overview